Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

01 juil. 2025 09h00 HE | Source: Stereotaxis, Inc.

First Clinical Results from MAGiC Catheter Study Published in the Journal of Interventional Cardiac Electrophysiology

ST. LOUIS, July 01, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the...
12 mai 2025 16h01 HE | Source: Stereotaxis, Inc.

Stereotaxis Reports 2025 First Quarter Financial Results

ST. LOUIS, May 12, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial...
22 avr. 2025 07h00 HE | Source: Stereotaxis, Inc.

Stereotaxis to Report First Quarter 2025 Financial Results on May 12, 2025

ST. LOUIS, April 22, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it...
21 avr. 2025 08h00 HE | Source: Stereotaxis, Inc.

Stereotaxis to Feature First-Ever Live Demo of GenesisX Robotic System at HRS 2025

Stereotaxis to host live demo of its most accessible surgical robot yet, GenesisX, at HRS 2025.
19 mars 2025 08h01 HE | Source: Stereotaxis, Inc.

Stereotaxis Highlighted by NVIDIA at GTC Artificial Intelligence Conference and Accepted into NVIDIA Connect Program

ST. LOUIS, March 19, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that NVIDIA...
10 mars 2025 08h02 HE | Source: Stereotaxis, Inc.

Stereotaxis to Present at 37th Annual Roth Conference

ST. LOUIS, March 10, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that David...
03 mars 2025 07h32 HE | Source: Stereotaxis, Inc.

Stereotaxis Submits EMAGIN Catheter for Regulatory Clearance as it Pioneers Robotics for Endovascular Surgery

ST. LOUIS, March 03, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced FDA...
03 mars 2025 07h31 HE | Source: Stereotaxis, Inc.

Stereotaxis Submits First Ever Robotically Navigated High-Density EP Mapping Catheter for Regulatory Clearance

ST. LOUIS, March 03, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced FDA...
03 mars 2025 07h30 HE | Source: Stereotaxis, Inc.

Stereotaxis Reports 2024 Full Year Financial Results

ST. LOUIS, March 03, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial...
25 févr. 2025 08h03 HE | Source: Stereotaxis, Inc.

Stereotaxis to Present at 45th Annual TD Cowen Healthcare Conference

ST. LOUIS, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that David...

Page précédente

Page suivante